| Previous Close | 2.9400 |
| Open | 2.9000 |
| Bid | 2.9900 x 0 |
| Ask | 3.0000 x 0 |
| Day's Range | 2.8400 - 3.0100 |
| 52 Week Range | 0.2600 - 3.7700 |
| Volume | 110,676 |
| Avg. Volume | 371,642 |
| Market Cap | 253.804M |
| Beta (5Y Monthly) | 1.16 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0190 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
ZEN Graphene Solutions Named to the TSX Venture 50
GUELPH, ON / ACCESSWIRE / February 24, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a next-gen nanomaterials technology company, is pleased to announce that it has been recognized as a Venture 50 company by the TSX Venture Exchange for 2020.
- CNW Group
Federal funds aid KAIROS and partner support to agriculture workers
18M in funding to assist temporary foreign workers who are affected by COVID OTTAWA, ON, Feb. 17, 2021 /CNW/ - KAIROS Canada is pleased to announce that the Government of Canada has awarded it $2.
- ACCESSWIRE
ZEN Graphene Solutions Announces Initial Phase 2 Cytotoxicity Results for Its Graphene-Based Compound
GUELPH, ON / ACCESSWIRE / February 4, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX-V:ZEN) and (OTC:ZENYF) is pleased to announce very promising initial phase 2 results of the 7-day repeated dose safety testing from Nucro Technics for potential human pharmaceutical use of its graphene-based compound.
